All eyes were on Flavio Lima Bianchi as he kicked off day one of the 15th World Bispecific Summit yesterday in Boston with a compelling presentation on the evolving Bispecific space, sparking great interest and discussions. Attendees were eager to get their hands on the slides, impressed by the forward-thinking insights and predictions for this rapidly changing field! If you'd like to see the data and analysis for yourself, reach out to our Account Manager Harvey Dennis. Discover how you can leverage the data in our database to stay ahead of the competition and best inform your pipelines for future success. Day 2 is here, and we’re excited to hear more from expert speakers, network with trailblazers in the field, and dive deeper into the exciting and ever-evolving landscape! Also, catch Beacon at the booth for some free goodies. #worldbispecific #antibody #antibodydiscovery #antibodytherapeutics #antibodyenginnering #bispecific #bispecificantibody
Beacon
Research Services
A preclinical, clinical trial and drug database solution built in partnership with the world’s leading experts.
About us
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape. With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.
- Website
-
https://www.beacon-intelligence.com
External link for Beacon
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Clinical Trials Data and Analysis, Antibiody Drug Conjugates [ADCs], Immuno Oncology, IO Combination Therapies, Targeted Therapies, Checkpoint Monotherapies, Checkpoint Combination, Clinical research developments, Preclinical, Antibody Drug Conjugates, CAR-T Therapies, CAR-T, TCR, TCR Therapies, Bispecifics, Multispecifics, Clinical Trials, Preclinical, Clinical Trial Intelligence, Clinical Trials Database, Beacon Targeted Therapies, Targeted Therapies, Trispecifics, ADCs, Immuno-oncology, NK Cell Engagers, T Cell Engagers, Natural Killer Cell Engagers, Adoptive Cell, and Gene Therapy
Locations
-
Primary
Hanson Wade 52 Grosvenor Gardens
London, SW1W 0AU, GB
Employees at Beacon
-
Kanagaraj Radhakrishnan, Ph. D.
Research & Education | Key Opinion Leader | Founder: 'Have Heart, Save Lung' - Dr. Chellamma's Group
-
Lucy Curran
Senior Marketing Manager at Beacon
-
Irina Ifrim
Senior Marketing Manager at Beacon
-
Jacob Pacey
Supporting industry leaders with insights to inform better drug development decisions 💉
Updates
-
🌟 Congratulations to Arsenal Biosciences, Inc. on raising over $300M! 🌟 Today marks a significant milestone in the cell therapy landscape, particularly with Arsenal Bio's innovative approach to CAR-T therapies targeting solid tumors through their dual-targeted CAR technology. This advancement holds tremendous potential for patients, and we’re excited to see how it evolves! At Beacon, we are proud to be at the forefront of tracking innovations in this field. We offer the most comprehensive insights, including precise tracking of all 320+ dual-targeted CARs currently in development. 🔍 Curious about the landscape? Check out the number of dual-targeted CARs by status! Together, we can continue to push the boundaries of what's possible in cell therapy! #CellTherapy #CAR_T #ArsenalBio #Biotech #Innovation #Beacon
-
🚀 Join us at the inaugural ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit! We’re excited to announce that our expert Senior ADC Account Manager, Jake Morris, will be presenting on "Clinical Data, Deals & Company Analysis Across the ADCs & Radiopharmaceuticals." During this session, we'll explore key clinical and partnership developments, analyze venture investment trends in early discovery and preclinical science, and examine the growing number of global partnerships, particularly those with Asia. Learn the full details here 👉https://ter.li/nweryj 👈 Don't miss this deep dive into the evolving world of ADCs and radiopharmaceuticals! We look forward to seeing you in Boston! #ADCPartnering #ADCs #Radiopharma #GlobalPartnerships #ADCInvestment #Biotech
-
The countdown is on ⏳ We’re gearing up for another exciting attendance at the 9th CAR-TCR Summit in Boston! Our Senior Research Analyst, Rachel East, will present "A Landscape Overview of CAR & TCR Therapies," evaluating current trends in the CAR & TCR therapy landscape and how platform technologies and innovations drive this competitive space. Plus, see how Beacon insights can accelerate the clinical development of your cell therapy pipeline! Download the full brochure to access further details 👇 https://ter.li/6lvd64 Keep your eyes peeled for more exciting Beacon announcements as we lead up to the event! 🎯 #cartcr #cartcrtherapies #celltherapy #drugdiscovery #drugdevelopment #clinicalresearch #preclinical #celltherapymanufacturing
-
📢 Exciting Announcement! We are thrilled to join the esteemed speaker faculty at the 15th Annual World Bispecific Summit in Boston. Our Lead Research Analyst, Flavio Lima Bianchi, will be presenting on "A Review of the Bispecific Landscape: The Past, The Present & The Future of Biologics." In this insightful session, we'll be: 🔬 Reviewing the current drug and trial landscape 📈 Discussing emerging trends in the bispecific landscape 💼 Outlining what the future holds for the bispecific space Get the full details about Flavio's opening presentation today - https://ter.li/ql8ezu We can’t wait to connect with industry leaders and contribute to the conversation! See you there! #worldbispecific #antibody #antibodydiscovery #antibodytherapeutics #antibodyenginnering #bispecific #bispecificantibody
-
📣 Dive Deeper into STING & TLR Innovations! 🚀 Missed our recent webinar, "Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape"? Don't worry, you can still catch up! Watch the session on demand to explore the latest advancements in the STING & TLR pipeline, discover new combination therapies, and dive into innovative strategies shaping the future of treatment. 🔗 Watch Now: https://ter.li/z3x8at Stay informed and ahead in the dynamic field of STING & TLR-targeted therapies! #ImmunoOncology #STING #TLR #Checkpoint
-
Missed our live webinar on the latest in Inflammatory Bowel Disease (IBD) treatments? No worries! You can now watch it on demand. Catch up on all the insights into key drug modalities, recent approvals, market growth drivers, and more at your convenience. 🎥 Watch Now: https://ter.li/1rh5bs Stay informed and explore the cutting-edge developments driving the IBD market from Beacon Immune Tolerance and Hanson Wade Intelligence! #InflammatoryBowelDisease #IBD #JAKinhibitors #TNFalphas #S1Preceptors #DrugTrends #MarketAnalysis
-
🔬 Thrilled to be part of the Microbiome Movement Drug Development Summit in Boston once again this year! And a special shoutout to our Microbiome Research Analyst, Ada Lam, for her stellar presentation. Offering a comprehensive analysis of the US and Asian markets and an in-depth examination of LBP development, Ada took a deep dive into how the microbiome space is demonstrating significant resilience and growth! To get a glimpse of the latest data delivered, contact our team Rais Malik or Callum Sleath directly, or get in touch at [email protected]. #MicrobiomeMovement #DrugDevelopment #BiotechInnovation
-
🔥 Exciting News! Missed our recent STING & TLR webinar? We've got you covered! You can now watch "Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape" on demand! 🧬 Catch up on the latest advancements in the STING & TLR pipeline, discover promising combination therapies, and explore innovative strategies driving this field at your convenience. 🔗 Watch On Demand: https://ter.li/z3x8at Don't miss out on staying at the forefront of STING & TLR-targeted treatment innovations! #ImmunoOncology #STING #TLR #Checkpoint
-
Discover the latest trends in early-stage biopharma investments with our comprehensive report, "Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective." From Series A financing peaks to the dominance of biologicals and the resurgence of biopharma IPOs, get all the insights you need to stay ahead in the market. 📥 Download your free copy today! 👉 https://ter.li/wtpcs3 #Biopharma #InvestmentTrends #SeriesAFinancing #BeaconData #MarketInsights #InvestmentStrategy